4.6 Article

Gam1-associated alterations of drug responsiveness through activation of apoptosis

期刊

MOLECULAR CANCER THERAPEUTICS
卷 6, 期 6, 页码 1823-1830

出版社

AMER ASSOC CANCER RESEARCH
DOI: 10.1158/1535-7163.MCT-06-0771

关键词

-

类别

资金

  1. NCI NIH HHS [R01 CA102630, CA102630, CA40570] Funding Source: Medline
  2. NATIONAL CANCER INSTITUTE [R01CA102630, R01CA040570] Funding Source: NIH RePORTER

向作者/读者索取更多资源

An early gene product, Gam1, encoded by the avian adenovirus CELO, is an inhibitory protein for the sumoylation machinery, which has been implicated in regulating a variety of cellular pathways. In this study, we found that Gam1 effectively suppressed both constitutive and inducible sumoylation and caused significant cell growth inhibition. This Gam1-mediated cell growth inhibition was associated with induction of apoptosis. In particular, Gam1 induced caspase-3 activity as detected by immunostaining and Western blot. Of interest, like the Ubc9 dominant-negative mutant, Gam1 also sensitized cells to DNA-damaging agents such as topotecan and doxorubicin and non-DNA-damaging agents such as paclitaxel and vincristine. Taken together, our findings suggest that activation of the caspase pathways is at least in part responsible for the increased apoptosis in Gam 1-expressing cells and, thus, contributes to the growth inhibition and enhanced chemosensitivity.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据